Efficacy and safety of oral melatonin in patients with severe COVID-19: a randomized controlled trial

Patients with COVID-19 have shown melatonin deficiency. We evaluated the efficacy and safety of administration oral melatonin in patients with COVID-19-induced pneumonia. Patients were randomly assigned in a 1:1 ratio to receive melatonin plus standard treatment or standard treatment alone. The prim...

Descripción completa

Detalles Bibliográficos
Autores principales: Ameri, Ali, Frouz Asadi, Masoomeh, Ziaei, Ava, Vatankhah, Majid, Safa, Omid, Kamali, Manoochehr, Fathalipour, Mohammad, Mahmoodi, Masoumeh, Hassanipour, Soheil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676876/
https://www.ncbi.nlm.nih.gov/pubmed/36401728
http://dx.doi.org/10.1007/s10787-022-01096-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9676876/
https://www.ncbi.nlm.nih.gov/pubmed/36401728
http://dx.doi.org/10.1007/s10787-022-01096-7

Ejemplares similares